NCT06691477Completed
A Cut-off Value Study of N-terminal Brain Natriuretic Peptide （Chemiluminescence Method）
Source: ClinicalTrials.gov · Last updated 15 Nov 2024
Brief summary (registry, in English)
The aim of the study is to evaluate diagnostic performance of N-terminal Brain natriuretic Peptide (NT-proBNP) in acute heart failure among Chinese population. Further, it sought to explore the optimal cut-off point fitting Chinese patients.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 1104 (actual)
- First submitted
- 14 Nov 2024
- Start date
- 10 Apr 2023
- Primary completion date
- 18 Sept 2024
- Lead sponsor
- Beckman Coulter, Inc.
- Diseases
- Heart failure, Coronary artery disease
- NCT number
- NCT06691477
What you commit to
- Study type: Observational
- Participants enrolled: 1104
- From 10 Apr 2023 to the primary completion date, 18 Sept 2024
- 4 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Chronic kidney disease stage 4 or 5.
Other
- Chronic renal dialysis.
- Participation in clinical studies that may interfere with participation in this study;
- Any behavior that would increase the subject's risk or prevent the subject from fully complying with or completing this study;
- The sample size is not enough for testing;
- Hemolysis, lipidemia or jaundice may be visible to the naked eye in the sample.
Who the study is looking for
- Age: ≥ 18 years old to voluntarily participate in this study and sign the informed consent form.
- Subjects Remaining serum or plasma sample size \> 500 ml.
- Have symptoms that would make the investigator suspect that they are related to heart failure.
- Dyspneic patients presenting to 3 EDs in China were enrolled and had sufficient blood for subsequent NT-proBNP measurement.
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (4)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Beijing Anzhen Hospital, Capital Medical University Coordinator of this site? Confirm its status | Beijing | China | Unknown status |
| Sun Yat-sen Memorial Hospital Coordinator of this site? Confirm its status | Guangzhou | China | Unknown status |
| The Second Affiliated Hospital of Gungzhou Medical University Coordinator of this site? Confirm its status | Guangzhou | China | Unknown status |
| Beckman Coulter Coordinator of this site? Confirm its status | Shanghai | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.